134 related articles for article (PubMed ID: 23076480)
1. [Early insulin therapy in type 2 diabetes?].
Birkeland KI
Tidsskr Nor Laegeforen; 2012 Oct; 132(19):2151-2. PubMed ID: 23076480
[No Abstract] [Full Text] [Related]
2. Comments on ORIGIN trial.
Mazzucchelli C; Bordone C; Maggi D; Cordera R
Nutr Metab Cardiovasc Dis; 2013 Aug; 23(8):e33-4. PubMed ID: 23786822
[No Abstract] [Full Text] [Related]
3. ORIGIN trial shows safety and efficacy of insulin glargine: no adverse cardiovascular outcomes after a 6.2-year follow up of early insulin use.
Lombard L; Distiller L; Aalbers J
Cardiovasc J Afr; 2012 Jul; 23(6):357-8. PubMed ID: 23091824
[No Abstract] [Full Text] [Related]
4. n-3 fatty acids and cardiovascular outcomes in dysglycemia.
Hurtado-Torres GF; Sandoval-Munro RL
N Engl J Med; 2012 Nov; 367(18):1760-1; author reply 1761. PubMed ID: 23113492
[No Abstract] [Full Text] [Related]
5. n-3 fatty acids and cardiovascular outcomes in dysglycemia.
Levy Y
N Engl J Med; 2012 Nov; 367(18):1760; author reply 1761. PubMed ID: 23113491
[No Abstract] [Full Text] [Related]
6. Basal insulin and cardiovascular and other outcomes.
Leow MK
N Engl J Med; 2012 Nov; 367(18):1763; author reply 1763-4. PubMed ID: 23113497
[No Abstract] [Full Text] [Related]
7. Basal insulin and cardiovascular and other outcomes.
Ceriello A
N Engl J Med; 2012 Nov; 367(18):1762-3; author reply 1763-4. PubMed ID: 23113496
[No Abstract] [Full Text] [Related]
8. Basal insulin and cardiovascular and other outcomes.
Schernthaner G; Currie CJ
N Engl J Med; 2012 Nov; 367(18):1762; author reply 1763-4. PubMed ID: 23113495
[No Abstract] [Full Text] [Related]
9. Basal insulin and cardiovascular and other outcomes.
Vigneri R; Vigneri P; Frittitta L
N Engl J Med; 2012 Nov; 367(18):1761-2; author reply 1763-4. PubMed ID: 23113494
[No Abstract] [Full Text] [Related]
10. The diabetologist/cardiologist debate: a meeting of the minds.
Mohamed F; Aalbers J
Cardiovasc J Afr; 2012 Mar; 23(2):115-7. PubMed ID: 22447480
[No Abstract] [Full Text] [Related]
11. N-3 fatty acids did not reduce major cardiovascular events in patients with dysglycaemia.
Kromhout D
Evid Based Med; 2013 Aug; 18(4):e34. PubMed ID: 23173155
[No Abstract] [Full Text] [Related]
12. Insulin detemir (levemir), a new long-acting insulin.
Med Lett Drugs Ther; 2006 Jul; 48(1238):54-5. PubMed ID: 16841022
[TBL] [Abstract][Full Text] [Related]
13. [What has the largest study in the history of diabetology brought us?].
Rusavý Z; Lacigová S; Kvapil M
Vnitr Lek; 2013 Mar; 59(3):160-4. PubMed ID: 23713181
[TBL] [Abstract][Full Text] [Related]
14. Insulin degludec for diabetes mellitus.
Drug Ther Bull; 2013 Jul; 51(7):78-81. PubMed ID: 23842634
[TBL] [Abstract][Full Text] [Related]
15. Insulin degludec/liraglutide (Xultophy 100/3.6) for type 2 diabetes.
Med Lett Drugs Ther; 2017 Sep; 59(1529):147-149. PubMed ID: 28880845
[No Abstract] [Full Text] [Related]
16. [Basal insulin has a "neutral effect" on cardiovascular events].
Overbeck P
MMW Fortschr Med; 2012 Jun; 154(12):24. PubMed ID: 22880290
[No Abstract] [Full Text] [Related]
17. Improved glycaemic control with no weight gain: a 26-week, open label, non-randomised, non-interventional observational study on type 2 diabetes subjects using insulin detemir.
Tripathi S; Chandalia HB; Rao PV; Badgandi M; Patni R; Subbanna PK; Shetty R; Kumar H
J Indian Med Assoc; 2011 Apr; 109(4):275-8. PubMed ID: 22187803
[TBL] [Abstract][Full Text] [Related]
18. Lessons from glargine trials: what is the goal fasting glucose with basal insulin?
Bloomgarden Z; Handelsman Y
J Diabetes; 2014 Jul; 6(4):271-3. PubMed ID: 24656089
[No Abstract] [Full Text] [Related]
19. Early insulin treatment in type 2 diabetes: ORIGINal sin or valuable choice as ORIGINal treatment? An open debate on the ORIGIN study results.
Bolli GB; Consoli A; Giaccari A
Nutr Metab Cardiovasc Dis; 2012 Dec; 22(12):1007-12. PubMed ID: 23199612
[TBL] [Abstract][Full Text] [Related]
20. [Diabetes mellitus type 1 and 2. Flexible therapy with insulin degludec].
Rausch R
Med Monatsschr Pharm; 2014 Jul; 37(7):273-4. PubMed ID: 25065174
[No Abstract] [Full Text] [Related]
[Next] [New Search]
